Austrian Medical Chamber calls for more physician-run house pharmacies in rural areas

On 26 August 2026 the Austrian Medical Chamber (Österreichische Ärztekammer, ÖÄK) held a press conference at the Press Club Concordia in Vienna to present a study by the consultancy network Kreutzer Fischer & Partner and to call for a broader rollout of physician-run 'Hausapotheken' — medical practices that dispense prescription medicines directly to patients. The ÖÄK materials name the participants at the event, including ÖÄK President Johannes Steinhart, Vice President OMR Dr Edgar Wutscher, Silvester Hutgrabner (head of the chamber’s house pharmacy department) and study author Andreas Kreutzer.

The chamber distributed a press pack and slide deck summarising the study's modelling and conclusions. The presentation frames the proposal as a measure to improve access to medicines in less densely populated regions and as a potential contributor to broader social and environmental objectives.

The ÖÄK-released materials highlight two headline impacts: financial savings and lower greenhouse-gas emissions. According to the study, a nationwide expansion of physician-run house pharmacies could save at least €160 million per year in economic costs. These figures aggregate effects such as reduced travel times for patients and avoided productivity losses.

The chamber's presentation also cites an estimated reduction of roughly 30,000 tonnes of CO2 annually from fewer private-car trips to collect prescription medications. Both numbers appear in the slides and the published press materials. The documentation provides methodological outlines, but the highest-level public summary does not show all underlying assumptions — for example, the exact patient counts, regional selection or valuation of time used in the calculations.

The ÖÄK bases its call on an access problem faced by patients in rural Austria: long distances to pharmacies and the burden of repeated trips, especially for elderly people and those with limited mobility. Physician-run dispensing is presented as a way to reduce that burden by making prescribed medications available directly after a medical consultation.

In the study’s scenarios, house pharmacies would be particularly helpful for chronically ill patients and for follow-up treatments where medications are routinely required. The consultancy modelled several expansion scenarios and quantified their effects on travel kilometres saved, time saved for patients and overall economic benefits in those variants.

Despite the headline benefits, the proposal raises a number of practical and regulatory issues that the ÖÄK materials touch upon but do not fully resolve. Key questions include what legal changes would be required to authorise wider physician dispensing, how quality control for storage and dispensing would be enforced, and how liability would be allocated when medicines are dispensed by medical practice staff.

Supply-chain arrangements also matter: would house pharmacies be centrally supplied, how would stock shortages be handled, and what would be the impact on the business model of existing community pharmacies in rural areas? The study’s public summary acknowledges these concerns but leaves many implementation details open, noting the proposal as a policy option rather than a final blueprint.

By publishing the study and publicising the proposal, the ÖÄK aims to launch a policy discussion that could involve parliamentary committees, the health ministry and the social insurance bodies. The chamber's materials provide numeric arguments that could be used in such debates, but they do not present legislative texts or a timetable for change.

Reactions from other stakeholders are not included in the chamber’s press pack. It can be expected that questions about the future role of community pharmacies, the allocation of dispensing responsibilities, and the responsibilities of payers will feature prominently in ensuing debates. The ÖÄK suggests piloting approaches and collecting further empirical evidence before any wide-ranging legal changes are implemented.

What is documented is straightforward: the ÖÄK presented a study by Kreutzer Fischer & Partner on 26 August 2026, which models the effects of expanding physician-run house pharmacies and provides headline estimates for cost and CO2 savings. Those figures appear in the ÖÄK slide deck and press materials disseminated after the event.

What remains uncertain concerns implementation. The study does not provide a final operational plan: it leaves open questions about requisite legal amendments, detailed financing mechanisms, supervision and coordination with existing pharmacies. The publication functions as the chamber’s policy proposal to stimulate discussion, not as an exhaustive implementation manual.